{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_c5_inhibitors",
          "name": "C5 Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_complement_inhibitors",
          "name": "Complement Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_fostamatinib",
          "name": "Fostamatinib"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_luspatercept",
          "name": "Luspatercept"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thrombopoietin_receptor_agonists",
          "name": "Thrombopoietin receptor agonists"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_risk_cin",
          "type": "Phenotype",
          "label": "CIN (Contrast-Induced Nephropathy)",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk_infection",
          "type": "Phenotype",
          "label": "Infection Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk_thrombosis",
          "type": "Phenotype",
          "label": "Thrombosis Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_c5_inhibitor",
          "type": "Target",
          "label": "C5 Inhibitor Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_complement_inhibition",
          "type": "Target",
          "label": "Complement System Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cin_mechanism",
          "type": "Pathway",
          "label": "CIN Mechanism Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infection_mechanism",
          "type": "Pathway",
          "label": "Infection Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_thrombosis_mechanism",
          "type": "Pathway",
          "label": "Thrombosis Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "n_ot_c5_inhibitor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致非特异性靶向效应"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_ot_c5_inhibitor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发旁路作用"
        },
        {
          "source": "n_ot_c5_inhibitor",
          "target": "n_ot_cin_mechanism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与 CIN 机制相关"
        },
        {
          "source": "n_ot_c5_inhibitor",
          "target": "n_ot_infection_mechanism",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能增加感染风险"
        },
        {
          "source": "n_ot_c5_inhibitor",
          "target": "n_ot_thrombosis_mechanism",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "与血栓形成机制相关"
        },
        {
          "source": "n_ot_cin_mechanism",
          "target": "n_risk_cin",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在的 CIN 风险"
        },
        {
          "source": "n_ot_infection_mechanism",
          "target": "n_risk_infection",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "提高感染风险"
        },
        {
          "source": "n_ot_thrombosis_mechanism",
          "target": "n_risk_thrombosis",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致血栓风险"
        },
        {
          "source": "n_risk_cin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "以上风险影响 Eculizumab 的效果"
        },
        {
          "source": "n_risk_infection",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "感染风险与治疗效果相悖"
        },
        {
          "source": "n_risk_thrombosis",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "血栓风险与合并症相悖"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "Drug Side Effects vs Benefits",
          "pro_nodes": [
            "H1",
            "H2",
            "H3"
          ],
          "con_nodes": [
            "n_risk_cin",
            "n_risk_infection",
            "n_risk_thrombosis"
          ],
          "note": "药物潜在风险与治疗的正面效果可能存在冲突"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "可能引发 CIN 及相关并发症，与预期益处相悖",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "感染风险可能影响治疗效果",
        "confidence": "high"
      },
      {
        "id": "K3",
        "text": "血栓风险与治疗目的相悖",
        "confidence": "high"
      }
    ],
    "assumptions_challenged": [
      "C5 抑制是否具有足够安全性支持治疗",
      "潜在的感染和并发症对疗效的影响"
    ],
    "falsification_tests": [
      "是否存在显示治疗效果可以超过潜在风险的证据？",
      "对照试验是否已证明长期安全性？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供对冲突热点的进一步解释",
      "再次评估对风险链的潜在影响"
    ]
  }
}